En IBC Group siempre estamos atentos a las innovaciones que fortalecen la seguridad y transparencia en la importación y regulación de dispositivos médicos , y una de las noticias más interesantes que está surgiendo desde Chile es el desarrollo de una herramienta basada en Inteligencia Artificial (IA) para apoyar la fiscalización de dispositivos médicos importados y su cumplimiento regulatorio . Recientemente, el Instituto de Salud Pública de Chile (ISP) fue seleccionado en e

Over the past two years, the Latin American medical device market has shown a clear and positive trend: distributors are actively diversifying their portfolios and seeking new international brands to meet stricter regulatory requirements and rising quality expectations from public hospitals, private clinics, and specialized centers. This shift is driven not only by regulatory evolution in countries like Colombia, Mexico, Peru, and Chile, but also by a deeper transformation in

For medical device manufacturers, expanding into Latin America represents a major opportunity. However, building a physical office, hiring local staff, navigating regulatory differences, and understanding each country’s commercial culture require time, investment, and significant risk. The modern and most effective alternative is strategic commercial representation — a model where a specialized partner like IBC GROUP acts as the manufacturer’s office in Latin America , opera

The availability of medical devices and essential supplies is a critical element of any healthcare system. However, recent international analyses reveal that Ecuador is facing a complex stage of supply shortages , directly affecting the continuity and quality of patient care. Although the government reports an availability rate close to 85%, healthcare professionals claim that the real situation is quite different: basic equipment is lacking, replenishment times are long , an

In the Peruvian medical-device landscape, a key segment is gaining traction: testing, inspection and certification services for medical devices prior to market entry. Although public-domain data is still limited, several market studies indicate that manufacturers, importers and distributors in Peru are increasingly facing regulatory, technological and quality demands — driving an opportunity for verification & validation service providers. Why is the scenario shifting? The P

A Clinical Research News article on August 14 2025 reports that Latin America is becoming a key region for “first-in-human” medical-device trials. Many medtech companies face obstacles in the U.S. or Europe—such as participant-shortage, long regulatory timelines or high costs—and are therefore turning to Latin American countries that offer faster ethics/regulation approval, adequate local investigators and lower cost. Countries such as Panama, El Salvador, Chile, Paraguay a

Uruguay issued Commercial Information Circular No. 393/2025, announcing implementation of Decree No. 498/025 which integrates into national law the MERCOSUR Common Market Group (GMC) Resolution No. 07/24. This resolution mandates that medical devices and in-vitro diagnostics (IVDs) meet enhanced safety and performance requirements for MERCOSUR member states. The decree means that device importers, distributors and manufacturers in Uruguay must align their products and docum

In Ecuador, the regulatory body ARCSA has issued new provisions affecting both medical devices and health-care supplies. Under resolution ARCSA-DE-2024-047-DASP, signed 12 December 2024 and effective June 2025, the country broadens and tightens requirements for establishments involved in storage, distribution and transport of medicines and medical devices. The announcement was made on 24 January 2025. Key changes include: (i) enhanced technical documentation for establishme

In Chile, the medical-device and digital-health industry is seeing notable growth driven by healthcare system modernization, increased remote-care demand and national digital-health policies. A 2025 analysis highlights that the country has improved telecommunications infrastructure, increased internet penetration and is incorporating connected devices (wearables, remote sensors) into public-health plans. The publication also points out that although device-registration proce

A recent industry analysis titled “The LATAM Pivot: MedTech’s Quiet Response to U.S. Tariff Volatility” shows that the global medical-device industry is increasingly turning its attention to Latin America in 2025 as a market-entry and supply-chain diversification strategy. The report notes that in April 2025 the U.S. administration imposed sweeping tariffs affecting device imports from more than 180 countries. Latin America emerges as an attractive alternative because of risi

Despite its relatively small size, Costa Rica has achieved a remarkable feat in the medical-device sector: according to a report dated May 19, 2025, the country now ranks as Latin America’s second-largest exporter of medical and precision-device equipment. The country’s success story begins with strategic industrial developments: a 1997 Intel assembly and testing plant laid the technological foundation that medical-device manufacturers later leveraged. Over the years, Costa

A recent study, released September 23 2025 by a medical-tech market firm, provides a detailed overview of registration costs and approval timelines in the three largest Latin American markets: Brazil, Mexico and Colombia. The paper emphasizes that while these markets offer significant revenue potential, they require a clear understanding of regulatory spending, translation needs, local representation and post-market compliance. For instance, in Brazil the document states t

The United Nations Economic Commission for Latin America and the Caribbean (ECLAC) recently urged Latin American countries to diversify their import and export markets in light of rising U.S. tariffs. Executive Secretary José Manuel Salazar called for deeper intra-regional integration and expansion of trade ties with Asia and Africa rather than over-reliance on any single external market. According to Salazar, the region should not only replace imports but broaden trade netw

In its updated September 2025 report, “Medical Device Manufacturing in Mexico [updated 2025]” highlights that Mexico has become a major global player in medical-device manufacturing: ranking seventh worldwide among device exporters and leading in Latin America. The report outlines how the country has developed several specialized clusters —for instance in Baja California/Sonora, Chihuahua, Jalisco and Nuevo León—that concentrate manufacture, R&D, assembly and exports of adva

In Mexico, regulatory authority COFEPRIS announced a new Abbreviated Regulatory Pathway for medical devices, effective September 1, 2025. The pathway allows device manufacturers to leverage existing approvals from international reference authorities (members of IMDRF or MDSAP) and importantly reduces documentation requirements, with a decision timeline of up to 30 business days. The July 18 2025 agreement stipulates that COFEPRIS will recognize decisions by other regulatory

A detailed analysis recently published outlines seven key regulatory trends for the medical-device sector in Latin America toward 2025. The article “7 Medical Device Regulatory Trends 2025 – LATAM You Need to Know” provides an in-depth view of the upcoming changes that will affect registration, importation, commercialization, surveillance and aftermarket service. The seven trends are: Regional regulatory harmonization : Initiatives in blocs such as Mercosur (Argentina, Braz

The medical-technology (MedTech) industry in Latin America is undergoing a phase of transformation and accelerated growth, driven by a mix of demographic, economic, regulatory and technological factors. As a recent article highlights, the regional MedTech market is projected to reach approximately USD 30.02 billion by 2025 , underscoring the scale of the opportunity. Key data points: Latin American governments are significantly increasing health-care investment, hospital inf

A Global Health Intelligence market analysis finds that from 2018 to 2023, imports of medical-device products and equipment from China into Latin American markets grew by approximately 27% in units and 39% in value , marking a structural shift in regional supply chains. In large markets such as Brazil, Colombia and Chile, Chinese-origin medical supplies now account for more than 50% of imports for certain consumable categories—indicating that European and U.S. manufacturers

The global MedTech industry is undergoing a subtle but significant strategic shift: according to the report “The LATAM Pivot: MedTech’s Quiet Response to U.S. Tariff Volatility”, many companies are rethinking their market-entry and supply-chain strategies and moving their attention toward Latin America (LATAM) in 2025. The report details that in April 2025, the U.S. administration imposed sweeping duties on over 180 countries, including direct tariffs on medical-device impor

In Latin America, the pandemic left a lasting mark: the realization that hospitals can never again afford to run out of gloves, syringes,...